Skip to content
2000
Volume 24, Issue 20
  • ISSN: 1385-2728
  • E-ISSN: 1875-5348

Abstract

The present pandemic erupted due to highly contagious coronavirus SARS-CoV- 2, and lack of any efficient therapy to restrain its infection and treatment, led the scientific community to re-evaluate the efficacy of commonly available phytochemicals as potential therapeutic agents. The vast pharmacological activities and medicinal significance of the plant-derived natural products against a diverse range of physiological disorders and diseases are well documented. Under the current health emergency across the world, there is an urgent requirement of repurposing of the available FDA approved drugs and natural products which could help in controlling the infections and alleviating the severity of the diseases as discovering entirely new chemical entity as a novel drug would be a protracted and costly journey. Some of the phytochemicals have already displayed potential anti-viral activity against different targets of SARS-CoV-2 virus. The present review would provide an account of the prevalent phytochemicals with antiviral activities, which would help in the development of promising drug therapy for the treatment of COVID-19 and similar such highly infectious viruses.

Loading

Article metrics loading...

/content/journals/coc/10.2174/1385272824999200910093524
2020-10-01
2025-05-21
Loading full text...

Full text loading...

/content/journals/coc/10.2174/1385272824999200910093524
Loading

  • Article Type:
    Review Article
Keyword(s): alkaloid; antiviral; COVID-19; flavonoids; Phytochemicals; terpenoids
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test